Single-Photon Emission Computed Tomography (SPECT) Market Report: Trends, Forecast and Competitive Analysis to 2030

Single-Photon Emission Computed Tomography (SPECT) Trends and Forecast

The future of the global single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets. The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030 with a CAGR of 10.0% from 2024 to 2030. The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

A more than 150-page report is developed to help in your business decisions.

Single-Photon Emission Computed Tomography (SPECT) by Segment

The study includes a forecast for the global single-photon emission computed tomography (SPECT) by product, application, end use, and region.

Single-Photon Emission Computed Tomography (SPECT) Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Standalone SPECT
• Hybrid SPECT

Single-Photon Emission Computed Tomography (SPECT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cardiology
• Oncology
• General Imaging
• Neurology
• Others

Single-Photon Emission Computed Tomography (SPECT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Others

Single-Photon Emission Computed Tomography (SPECT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Single-Photon Emission Computed Tomography (SPECT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-photon emission computed tomography (SPECT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-photon emission computed tomography (SPECT) companies profiled in this report include-

• Siemens Healthineers
• Bruker
• Toshiba Medical
• Digirad
• Esaote
• Invicro
• GE Healthcare

Single-Photon Emission Computed Tomography (SPECT) Market Insights

• Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.

• Within this market, hospital will remain the largest segment due to growing numbers of patients being admitted to hospitals and rising adoption of SPECT equipment for diagnosis in this facility.

• North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Features of the Global Single-Photon Emission Computed Tomography (SPECT) Market

• Market Size Estimates: Single-photon emission computed tomography (SPECT) market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Single-photon emission computed tomography (SPECT) market size by various segments, such as by application, end use, and region. in terms of value ($B).

• Regional Analysis: Single-photon emission computed tomography (SPECT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and region.s for the single-photon emission computed tomography (SPECT) market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-photon emission computed tomography (SPECT) market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the single-photon emission computed tomography (SPECT) market size?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030.

Q.2. What is the growth forecast for single-photon emission computed tomography (SPECT) market?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to grow with a CAGR of 10.0% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the single-photon emission computed tomography (SPECT) market?

Answer: The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

Q.4. What are the major segments for single-photon emission computed tomography (SPECT) market?

Answer: The future of the single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets.

Q.5. Who are the key single-photon emission computed tomography (SPECT) market companies?

Answer: Some of the key single-photon emission computed tomography (SPECT) companies are as follows:

• Siemens Healthineers
• Bruker
• Toshiba Medical
• Digirad
• Esaote
• Invicro
• GE Healthcare

Q.6. Which single-photon emission computed tomography (SPECT) market segment will be the largest in future?

Answer: Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.

Q.7. In single-photon emission computed tomography (SPECT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the single-photon emission computed tomography (SPECT) market by product (standalone SPECT and hybrid SPECT), application (cardiology, oncology, general imaging, neurology, and others), end use (hospitals, diagnostic imaging centers, ambulatory surgical centers, and others)and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?